Cargando…
Recipients of COVID-19 vaccines face challenges of SARS-CoV-2 variants
The coronavirus disease 19 (COVID-19) has been rampant since 2019, severely affecting global public health, and causing 5.75 million deaths worldwide. So far, many vaccines have been developed to prevent the infection of SARS-CoV-2 virus. However, the emergence of new variants may threat vaccine rec...
Autores principales: | Li, Tianhong, Luo, Kathy Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305267/ https://www.ncbi.nlm.nih.gov/pubmed/35874950 http://dx.doi.org/10.7150/ijbs.72424 |
Ejemplares similares
-
Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants
por: Chaqroun, Ahlam, et al.
Publicado: (2021) -
Mortality Due to COVID-19 in Renal Transplant Recipients, Related to Variants of SARS-CoV-2 and Vaccination in Mexico
por: Rivera, Juan Carlos H Hernández, et al.
Publicado: (2022) -
Managing waning vaccine protection against SARS-CoV-2 variants
por: Leung, Kathy, et al.
Publicado: (2022) -
Role of COVID-19 Vaccines in SARS-CoV-2 Variants
por: Zhou, Zhou, et al.
Publicado: (2022) -
SARS-CoV-2 Variants and Vaccines
por: Krause, Philip R., et al.
Publicado: (2021)